Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

News Daily News

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

March 15, 2023

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

Hydroxychloroquine Fails to Prevent COVID-19 in Those Exposed to the Virus: RCT

News Daily News

Hydroxychloroquine Fails to Prevent COVID-19 in Those Exposed to the Virus: RCT

June 05, 2020

News Daily News

与华法林或阿司匹林相比，阿哌沙班更具成本效益

February 26, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

February 26, 2014

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

July 12, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.